{"id":"https://openalex.org/W4366981225","doi":"https://doi.org/10.1016/j.msard.2023.104733","title":"Ublituximab: A new FDA-approved anti-CD20 mAb for relapsing forms of multiple sclerosis","display_name":"Ublituximab: A new FDA-approved anti-CD20 mAb for relapsing forms of multiple sclerosis","publication_year":2023,"publication_date":"2023-04-25","ids":{"openalex":"https://openalex.org/W4366981225","doi":"https://doi.org/10.1016/j.msard.2023.104733","pmid":"https://pubmed.ncbi.nlm.nih.gov/37156035"},"language":"en","primary_location":{"id":"doi:10.1016/j.msard.2023.104733","doi":"https://doi.org/10.1016/j.msard.2023.104733","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.msard.2023.104733","pdf_url":null,"source":{"id":"https://openalex.org/S2764622253","display_name":"Multiple Sclerosis and Related Disorders","issn_l":"2211-0348","issn":["2211-0348","2211-0356"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Multiple Sclerosis and Related Disorders","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084473985","display_name":"Vinicius de Oliveira Boldrini","orcid":"https://orcid.org/0000-0003-3984-2689","observed_orcids":["https://orcid.org/0000-0003-3984-2689"]},"institutions":[{"id":"https://openalex.org/I181391015","display_name":"Universidade Estadual de Campinas (UNICAMP)","ror":"https://ror.org/04wffgt70","country_code":"BR","type":"education","lineage":["https://openalex.org/I181391015"]},{"id":"https://openalex.org/I4210144446","display_name":"Brazilian Institute of Neuroscience and Neurotechnology","ror":"https://ror.org/044ydn458","country_code":"BR","type":"facility","lineage":["https://openalex.org/I4210144446"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Vin\u00edcius Oliveira Boldrini","raw_affiliation_strings":["Neuroimaging Laboratory, Department of Neurology, University of Campinas, Campinas, S\u00e3o Paulo, Brazil; Brazilian Institute of Neuroscience and Neurotechnology (BRAINN), University of Campinas, Campinas, S\u00e3o Paulo, Brazil"],"raw_orcid":"https://orcid.org/0000-0003-3984-2689","affiliations":[{"raw_affiliation_string":"Neuroimaging Laboratory, Department of Neurology, University of Campinas, Campinas, S\u00e3o Paulo, Brazil; Brazilian Institute of Neuroscience and Neurotechnology (BRAINN), University of Campinas, Campinas, S\u00e3o Paulo, Brazil","institution_ids":["https://openalex.org/I181391015","https://openalex.org/I4210144446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091389012","display_name":"Simone Mader","orcid":"https://orcid.org/0000-0002-2844-9091","observed_orcids":["https://orcid.org/0000-0002-2844-9091"]},"institutions":[{"id":"https://openalex.org/I4405261172","display_name":"Institut f\u00fcr Klinische Neuroimmunologie","ror":"https://ror.org/04x6wax64","country_code":"DE","type":"facility","lineage":["https://openalex.org/I3018771216","https://openalex.org/I4405261172","https://openalex.org/I8204097"]},{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Simone Mader","raw_affiliation_strings":["Institute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen, Munich, Germany; Biomedical Center (BMC), Medical Faculty, Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen, Martinsried, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen, Munich, Germany; Biomedical Center (BMC), Medical Faculty, Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen, Martinsried, Germany","institution_ids":["https://openalex.org/I4405261172","https://openalex.org/I8204097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021067270","display_name":"Tania K\u00fcmpfel","orcid":"https://orcid.org/0000-0001-7509-5268","observed_orcids":["https://orcid.org/0000-0001-7509-5268"]},"institutions":[{"id":"https://openalex.org/I4405261172","display_name":"Institut f\u00fcr Klinische Neuroimmunologie","ror":"https://ror.org/04x6wax64","country_code":"DE","type":"facility","lineage":["https://openalex.org/I3018771216","https://openalex.org/I4405261172","https://openalex.org/I8204097"]},{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Tania K\u00fcmpfel","raw_affiliation_strings":["Institute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen, Munich, Germany; Biomedical Center (BMC), Medical Faculty, Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen, Martinsried, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen, Munich, Germany; Biomedical Center (BMC), Medical Faculty, Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen, Martinsried, Germany","institution_ids":["https://openalex.org/I4405261172","https://openalex.org/I8204097"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5028837006","display_name":"Edgar Meinl","orcid":"https://orcid.org/0000-0002-2570-6785","observed_orcids":["https://orcid.org/0000-0002-2570-6785"]},"institutions":[{"id":"https://openalex.org/I3018771216","display_name":"LMU Klinikum","ror":"https://ror.org/02jet3w32","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I3018771216","https://openalex.org/I8204097"]},{"id":"https://openalex.org/I4405261172","display_name":"Institut f\u00fcr Klinische Neuroimmunologie","ror":"https://ror.org/04x6wax64","country_code":"DE","type":"facility","lineage":["https://openalex.org/I3018771216","https://openalex.org/I4405261172","https://openalex.org/I8204097"]},{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Edgar Meinl","raw_affiliation_strings":["Institute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen, Munich, Germany; Biomedical Center (BMC), Medical Faculty, Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen, Martinsried, Germany. Electronic address: edgar.meinl@med.uni-muenchen.de"],"raw_orcid":"https://orcid.org/0000-0002-2570-6785","affiliations":[{"raw_affiliation_string":"Institute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen, Munich, Germany; Biomedical Center (BMC), Medical Faculty, Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen, Martinsried, Germany. Electronic address: edgar.meinl@med.uni-muenchen.de","institution_ids":["https://openalex.org/I3018771216","https://openalex.org/I4405261172","https://openalex.org/I8204097"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2830,"currency":"USD","value_usd":2830},"apc_paid":null,"fwci":1.778,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.83892451,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"75","issue":null,"first_page":"104733","last_page":"104733"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ublituximab","display_name":"ublituximab","score":1.0},{"id":"https://openalex.org/keywords/anti-cd20-monoclonal-antibody","display_name":"anti-CD20 monoclonal antibody","score":0.9100000262260437},{"id":"https://openalex.org/keywords/relapsing-multiple-sclerosis","display_name":"relapsing multiple sclerosis","score":0.9459999799728394},{"id":"https://openalex.org/keywords/b-cell-depletion","display_name":"B-cell depletion","score":0.9010000228881836},{"id":"https://openalex.org/keywords/long-lived-plasma-cells","display_name":"long-lived plasma cells","score":0.8809999823570251},{"id":"https://openalex.org/keywords/glycoengineering","display_name":"glycoengineering","score":0.7710000276565552},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.8360000252723694},{"id":"https://openalex.org/keywords/ocrelizumab","display_name":"ocrelizumab","score":1.0},{"id":"https://openalex.org/keywords/ofatumumab","display_name":"ofatumumab","score":1.0},{"id":"https://openalex.org/keywords/teriflunomide","display_name":"teriflunomide","score":0.9909999966621399},{"id":"https://openalex.org/keywords/b-cell-targeted-therapy","display_name":"B cell-targeted therapy","score":0.5580000281333923}],"concepts":[{"id":"https://openalex.org/C2778843634","wikidata":"https://www.wikidata.org/wiki/Q2013780","display_name":"Ocrelizumab","level":4,"score":0.9531959295272827},{"id":"https://openalex.org/C2778714382","wikidata":"https://www.wikidata.org/wiki/Q410656","display_name":"Ofatumumab","level":4,"score":0.9323419332504272},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8754311800003052},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.7994877099990845},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.6943852305412292},{"id":"https://openalex.org/C2777703276","wikidata":"https://www.wikidata.org/wiki/Q3077133","display_name":"Teriflunomide","level":4,"score":0.6873792409896851},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.6387619972229004},{"id":"https://openalex.org/C18031839","wikidata":"https://www.wikidata.org/wiki/Q5009796","display_name":"CD20","level":3,"score":0.6326634287834167},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5093637704849243},{"id":"https://openalex.org/C163864487","wikidata":"https://www.wikidata.org/wiki/Q6901461","display_name":"Monoclonal","level":4,"score":0.4455658197402954},{"id":"https://openalex.org/C2779719350","wikidata":"https://www.wikidata.org/wiki/Q412920","display_name":"Daclizumab","level":4,"score":0.44295793771743774},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.42426615953445435},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4152667820453644},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.3450854420661926},{"id":"https://openalex.org/C2776036978","wikidata":"https://www.wikidata.org/wiki/Q425137","display_name":"Fingolimod","level":3,"score":0.3109738826751709},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2766672968864441}],"mesh":[{"descriptor_ui":"D000069283","descriptor_name":"Rituximab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009103","descriptor_name":"Multiple Sclerosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D018951","descriptor_name":"Antigens, CD20","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.msard.2023.104733","doi":"https://doi.org/10.1016/j.msard.2023.104733","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.msard.2023.104733","pdf_url":null,"source":{"id":"https://openalex.org/S2764622253","display_name":"Multiple Sclerosis and Related Disorders","issn_l":"2211-0348","issn":["2211-0348","2211-0356"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Multiple Sclerosis and Related Disorders","raw_type":"journal-article"},{"id":"pmid:37156035","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37156035","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Multiple sclerosis and related disorders","raw_type":"Letter"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W1990309284","https://openalex.org/W2141111992","https://openalex.org/W2561881161","https://openalex.org/W2565433170","https://openalex.org/W2740232610","https://openalex.org/W3025939368","https://openalex.org/W3033968144","https://openalex.org/W3047302551","https://openalex.org/W3203464297","https://openalex.org/W3203803649","https://openalex.org/W4220842043","https://openalex.org/W4220879604","https://openalex.org/W4224310539","https://openalex.org/W4225308128","https://openalex.org/W4293105031","https://openalex.org/W4309487094","https://openalex.org/W4318188468","https://openalex.org/W4320892170"],"related_works":["https://openalex.org/W4312726650","https://openalex.org/W4387661630","https://openalex.org/W4309487094","https://openalex.org/W7143463956","https://openalex.org/W4324311352","https://openalex.org/W3022913130","https://openalex.org/W4389460561","https://openalex.org/W4400694331","https://openalex.org/W4413797245","https://openalex.org/W4307853671"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-27T00:00:00"}